SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Karyopharm Extends Forbearance Period to November 1, 2026

Karyopharm Therapeutics extended the forbearance period under its forbearance agreement to November 1, 2026.

KPTI

Related stories